ABSTRACT Introduction: In Japan, there is free physical check-up programs of cancer screening, by which asymptomatic participants undergo a medical examination at public expense. The present study aims to describe their gynecologic findings and compare them with the literatures reported from general hospitals and self-paid check-up programs. Methods: Medical records of Japanese women, who underwent gynecological examinations at public expense between 2005 and 2009, were retrospectively reviewed. Results: Of the cervical smears from 2850 women aged 21 - 82 years, 33 (1.1%) were classified as dysplastic and malignant changes: 28 of low-grade squamous intraepithelial lesion (LSIL), 3 high-grade squamous intraepithelial lesion (HSIL), 2 atypical squamous cells of undeterimined significance (ASC-US). No case of cervical squamous cell carcinoma or adenocarcinoma was found. Ultrasonographic examination detected uterus enlargements and ovary tumors in less than 1% of cases. Most of participants (98%) revealed no gynecologic abnormalities. Conclusion: Annual gynecologic screening and proper follow-up programs even against asymptomatic women may remarkably reduce the probability of (pre)malignant disease.
Cite this paper
nullTakagi, H. , Ichigo, S. , Matsunami, K. and Imai, A. (2011) Evaluation of a public expense-covered gynecologic screening program in Japan 2005-2009. Open Journal of Obstetrics and Gynecology, 1, 21-24. doi: 10.4236/ojog.2011.12005.
 Anttila, A., Ronco, G., Clifford, G., Bray, F., Hakama, M., Arbyn, M. and Weiderpass, E. (2004) Cervical cancer screening programmes and policies in 18 European countries. British Journal of Cancer, 91, 935-941.
Bray, F., Loos, A., McCarron, P., Weiderpass, E., Arbyn, M., M?ller, H., Hakama, M. and Parkin, D. (2005) Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening. Cancer Epidemiology, Biomarkers & Prevention, 14, 677-686. doi:10.1158/1055-9965.EPI-04-0569
Greenlee, R., Hill-Harmon, M., Murray, T. and Thun, M. (2001) Cancer statistics, 2001. CA: A Cancer Journal for Clinicians, 51, 15-36. doi:10.3322/canjclin.51.1.15
Hakama, M., Coleman, M., Alexe, D. and Auvinen, A. (2008) Cancer screening: Evidence and practice in Europe 2008. European Journal of Cancer, 44, 1404-1413.
Johannesson, G., Geirsson, G., Day, N. and Tulinius, H. (1982) Screening for cancer of the uterine cervix in Iceland 1965-1978. Acta Obstetricia et Gynecologica Scandinavica, 61, 199-203.
Mount, S. and Papillo, J. (1999) A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England. Pediatrics, 103, 539-545.
Nieminen, P., Kallio, M., Anttila, A. and Hakama, M. (1999) Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study. International Journal of Cancer, 83, 55-58.
 Dietrich, A., Tobin, J., Cassells, A., Robinson, C., Greene, M., Sox, C., Beach, M., DuHamel, K. and Younge, R. (2006) Telephone care management to improve cancer screening among low-income women: A randomized, controlled trial. Annals of Internal Medicine, 144, 563-571.
Lawson, H., Henson, R., Bobo, J. and Kaeser, M. (2000) Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR—Recommendations and Reports, 49, 37-55.
Ng, E., Wilkins, R., Fung, M. and Berthelot, J. (2004) Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996. Canadian Medical Association Journal, 170, 1545-1549.
Schoenberg, N., Hopenhayn, C., Christian, A., Knight, E. and Rubio, A. (2005) An in-depth and updated perspective on determinants of cervical cancer screening among central Appalachian women. Women Health, 42, 89-105.
Yabroff, K., Lawrence, W., King, J., Mangan, P., Washington, K., Yi, B., Kerner, J. and Mandelblatt, J. (2005) Geographic disparities in cervical cancer mortality: What are the roles of risk factor prevalence, screening, and use of recommended treatment? The Journal of Rural Health, 21, 149-157. doi:10.1111/j.1748-0361.2005.tb00075.x
Mu?oz, N., Bosch, F., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K., Snijders, P. and Meijer, C. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine, 348, 518-527.
Rocha-Zavaleta, L., Yescas, G., Cruz. R. and Cruz-Talo- nia, F. (2004) Human papillomavirus infection and cervical ectopy. International Journal of Gynecology & Obstetrics, 85, 259-266. doi:10.1016/j.ijgo.2003.10.002
Tachezy, R., Saláková, M., Hamsíková, E., Kanka, J., Havránková, A. and Vonka, V. (2003) Prospective study on cervical neoplasia: Presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions. Sexually Transmitted Infections, 79, 191- 196. doi:10.1136/sti.79.3.191
Baseman, J. and Koutsky, L. (2005) The epidemiology of human papillomavirus infections. Journal of Clinical Virology, 32, S16-24. doi:10.1016/j.jcv.2004.12.008
Clavel, C., Masure, M., Bory, J., Putaud, I., Mangeonjean, C., Lorenzato, M., Nazeyrollas, P., Gabriel, R. and Quereux, C., Birembaut, P. (2001) Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: A study of 7932 women. British Journal of Cancer, 84, 1616-1623.
 Levy, B. (2008) Modern management of uterine fibroids. Acta Obstetricia et Gynecologica Scandinavica, 87, 812-823. doi:10.1080/00016340802146912
Parker, W. (2007) Uterine myomas: Management. Fertility and Sterility, 88, 255-271.
Sankaran, S. and Manyonda, I. (2008) Medical management of fibroids. Best Practice & Research Clinical Obstetrics & Gynecology, 22, 655-667.